Latest Articles
- ArticleNeuromyelitis optica spectrum disordersComparison according to the phenotype and serostatusMaria Sepúlveda, Thaís Armangué, Nuria Sola-Valls, et al.April 14, 2016
- EditorialAn older dog with newer tricksPredicting efficacy of IFN-β treatment for multiple sclerosisGregory F. Wu, Erin E. LongbrakeApril 07, 2016
- ArticleNatalizumab-induced POU2AF1/Spi-B upregulationA possible route for PML developmentMaria Meira, Claudia Sievers, Francine Hoffmann, et al.March 31, 2016
- Clinical/Scientific NotesRepeated treatments with rituximab in a patient with amyloid-like IgM deposition neuropathyMasato Kadoya, Akiko Kadoya, Hiroyuki Onoue, et al.March 31, 2016
- Clinical/Scientific NotesNeuromyelitis optica spectrum disorder in a patient with Kikuchi-Fujimoto diseaseMichelle Kaku, Susan Shin, Martin Goldstein, et al.March 31, 2016
- ArticleVoltage-gated calcium channel autoimmune cerebellar degenerationCase and study of cytotoxicityMarilyn McKasson, Stacey L. Clardy, Susan A. Clawson, et al.March 31, 2016
- ArticleInterleukin-7 treatment of PML in a patient with idiopathic lymphocytopeniaDhanashri P. Miskin, Spyridon G. Chalkias, Xin Dang, et al.March 21, 2016
- ArticleIL-17 production by CSF lymphocytes as a biomarker for cerebral vasculitisVivien Thom, Sabrina Schmid, Mathias Gelderblom, et al.March 21, 2016
- Clinical/Scientific NotesVZV in biopsy-positive and -negative giant cell arteritis: Analysis of 100+ temporal arteriesDon Gilden, Teresa White, Nelly Khmeleva, et al.March 09, 2016
Pages
Advertisement
Cutaneous α-Synuclein Signatures in Patients With Multiple System Atrophy and Parkinson Disease
Dr. Rizwan S. Akhtar and Dr. Sarah Brooker